Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 029385/0753 | |
| Pages: | 2 |
| | Recorded: | 11/30/2012 | | |
| Attorney Dkt #: | GRAD:1006 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/29/2013
|
Application #:
|
12913515
|
Filing Dt:
|
10/27/2010
|
|
Publication #:
|
|
Pub Dt:
|
05/19/2011
| | | | |
|
Title:
|
NOVEL THERAPEUTIC RNA INTERFERENCE TECHNOLOGY TARGETED TO THE PDX-1 ONCOGENE IN PDX-1 EXPRESSING NEUROENDOCRINE TUMORS
|
|
|
Assignee
|
|
|
|
|
| ONE BAYLOR PLAZA |
| HOUSTON, TEXAS 77030 |
|
|
Correspondence name and address
|
| |
CHALKER FLORES, LLP
|
| |
14951 NORTH DALLAS PARKWAY
|
| |
SUITE 400
|
| |
DALLAS, TX 75254
|
Search Results as of:
05/05/2024 01:27 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
